Knight Therapeutics Inc.
KHTRF
$4.72
$0.000.00%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -699.19% | -80.15% | 12,209.47% | 104.39% | 57.91% |
| Total Depreciation and Amortization | 8.69% | -13.37% | -5.09% | 2.00% | 3.13% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 462.88% | 112.63% | -524.03% | 767.35% | -105.12% |
| Change in Net Operating Assets | 216.87% | 7.90% | -8.21% | 7.58% | -175.81% |
| Cash from Operations | 472.40% | 143.68% | -71.47% | 563.35% | -103.47% |
| Capital Expenditure | -72.41% | 35.03% | -45.88% | 45.47% | 25.35% |
| Sale of Property, Plant, and Equipment | -- | -70.73% | -- | -- | -94.88% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -80.16% | 71.10% | 51.53% | -4.01% | 152.11% |
| Cash from Investing | -427.06% | 73.61% | 52.56% | -1.60% | 147.53% |
| Total Debt Issued | 5,947.21% | 233.15% | -66.85% | 119.28% | 37.06% |
| Total Debt Repaid | -1,963.55% | 66.00% | -162.35% | 61.63% | -203.03% |
| Issuance of Common Stock | 218.42% | -18.57% | -68.75% | 31.76% | 359.46% |
| Repurchase of Common Stock | 99.82% | 35.05% | -108.16% | -99.19% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -437.43% | 80.53% | -480.91% | 84.73% | -264.09% |
| Cash from Financing | 1,221.65% | 70.15% | -280.96% | 65.33% | -286.42% |
| Foreign Exchange rate Adjustments | -547.73% | -57.54% | 541.87% | 124.98% | -388.05% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -211.14% | 392.20% | -52.21% | 740.52% | -149.05% |